All Posts By

Ehave

Ehave to Explore Strategic Alternatives

By | Press Releases
Ehave, Inc. (OTCQB: EHVVF), a healthcare company dedicated to empowering the medical cannabis and mental health communities with next-generation digital solutions, announced today that its Board of Directors, supported by its management team, has engaged in a process of exploring...
Read More

CHILD-BRIGHT Network and Ehave Start Enrollment for Cognitive Rehabilitation Trial for Children with ADHD, Autism, and Congenital Heart Disease

By | MegaTeam, Press Releases
The CHILD-BRIGHT Mega Team game is an innovative video game-based cognitive intervention that aims to improve executive functions in children with brain-based developmental disabilities. The CHILD-BRIGHT Network, a Canadian patient-oriented research network focused on pediatric brain-based developmental disorders, and Ehave,...
Read More

Aequus and Ehave Enter into Collaboration Agreement for Comprehensive Patient Data Management in Clinical Trials of Medical Cannabis

By | Medical Cannabis, Press Releases
Ehave’s Bioinformatics Platform Technology to Be Used to Evaluate Aequus’ Products in Multiple Neurological Disorders Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products,...
Read More

Revive Therapeutics and Ehave Enter into Patient Research Data Collaboration Agreement for Medical Cannabis Liver Disease Program

By | Medical Cannabis, Press Releases
Revive Therapeutics Ltd. ("Revive") (TSX VENTURE: RVV) (OTCQB: RVVTF), a company focused on the research, development and commercialization of novel cannabinoid solutions, and Ehave, Inc. (“Ehave”) (OTCQB: EHVVF), a healthcare company dedicated to empowering the mental health community with next-generation...
Read More